Pulmonx Corp — Director's Dealing 2021

Jun 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-25

Reporting Person: Florin Daniel P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-25	Common Stock	P	2222	$44.12	Acquired	5032	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15789	Indirect

Footnotes

F1: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.68 to $44.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3: The shares are directly held by Kelly A Florin Trust, for which the Reporting Person is a trustee.